Genetic Testing to Inform Epilepsy Treatment Management From an International Study of Clinical PracticeDianalee McKnight, Susana Monroy, Joshua L. Bonkowsky et al.|JAMA Neurology|2022Cited by 97
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trialThomas O. Crawford, Barbara Steinborn, Eugenio Mercuri et al.|The Lancet Neurology|2025Cited by 22